Today, ClinCapture, Inc., a leading provider for Electronic Data Capture (EDC) systems and eClinical solutions, announced that it will begin offering EDC at no cost for specific clinical trials investigating COVID-19 Coronavirus
| SAN FRANCISCO, March 17, 2020 /PRNewswire/ -- Today, ClinCapture, Inc., a leading provider for Electronic Data Capture (EDC) systems and eClinical solutions, announced that it will begin offering EDC at no cost for specific clinical trials investigating COVID-19 Coronavirus. The decision to offer free EDC for BioPharma and Diagnostic companies conducting COVID-19 clinical trials was announced after the World Health Organization issued a statement that the confirmed number of COVID-19 cases has surpassed 100,000 globally.
ClinCapture is inspired by the response time, organization, and dedication to find solutions for COVID-19 demonstrated within the clinical research industry and would like to help these companies by offering free EDC for their trials. ClinCapture will be providing its Captivate EDC through the philanthropic Weidley’s Wish program which normally provides EDC to non-profit organizations conducting Rare Disease/Orphan Disease trials. “We are in a unique position in a unique point in history,” said ClinCapture CEO Scott Weidley. “Our commitment to act now will have a dramatic effect on our ability to help in the future.” ClinCapture’s Captivate EDC is a fully validated, cloud-hosted system designed to offer researchers more insight into their clinical data in order to bring treatments to market faster. To learn more about how ClinCapture can support your COVID-19 trials, please reach out to covid19trials@clincapture.com. A ClinCapture team member will contact you to provide more information. ClinCapture provides a powerful eClinical platform that enables sponsors and CROs to rapidly build and deploy studies, lower clinical trial costs, and streamline data capture processes. Offering a host of private cloud solutions, ClinCapture’s technologies help advance the evaluation and development of drugs, biologics, and devices that demonstrate promise for the diagnosis and/or treatment of a wide range of diseases or medical conditions. For more information, please visit clincapture.com or follow us at @ClinCapture.
SOURCE ClinCapture, Inc. |
View original content to download multimedia:
